Last update 01 Nov 2024

Tipapkinogene sovacivec

Overview

Basic Info

Drug Type
Recombinant vector vaccine, Shared antigen vaccine, Therapeutic vaccine
Synonyms
DNA (synthetic vaccinia virus strain MVA human papillomavirus-targeted), MVA-HPV-IL2 vaccine, Tipapkinogene sovacivec (USAN/INN)
+ [7]
Mechanism
E6 modulators(Protein E6 modulators), E7 modulators(Protein E7 modulators), MUC1 modulators(Mucin-1 modulators)
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D09682--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Human Papillomavirus-16 PositivePhase 2
US
11 Sep 2017
Human Papillomavirus-16 PositivePhase 2
FR
11 Sep 2017
Human Papillomavirus-16 PositivePhase 2
ES
11 Sep 2017
Human Papillomavirus-Related Anal Squamous Cell CarcinomaPhase 2
US
11 Sep 2017
Human Papillomavirus-Related Anal Squamous Cell CarcinomaPhase 2
FR
11 Sep 2017
Human Papillomavirus-Related Anal Squamous Cell CarcinomaPhase 2
ES
11 Sep 2017
Human Papillomavirus-Related Cervical CarcinomaPhase 2
US
11 Sep 2017
Human Papillomavirus-Related Cervical CarcinomaPhase 2
FR
11 Sep 2017
Human Papillomavirus-Related Cervical CarcinomaPhase 2
ES
11 Sep 2017
Human Papillomavirus-Related Squamous Cell Carcinoma of the PenisPhase 2
US
11 Sep 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
-
ilsfdzlpvw(ctytnbzlda) = qhxueptgrr raomqtqxej (zbmwckkrap )
-
11 Jul 2023
Phase 2
40
dcoeruianl(tqilvxbkba) = urcrmtegsa yrjmsdwfym (vmhpflzwfz )
Positive
26 May 2023
dcoeruianl(tqilvxbkba) = srakxshgof yrjmsdwfym (vmhpflzwfz )
Phase 1/2
54
erqnuuwjid(ozoyxzayvs) = xlbopjlgqo swsfsjmfmr (yndeptnzxj )
Positive
02 Nov 2022
Phase 2
34
hzodawoile(ywgtjhyqlk) = qwziseazxy budmfrkbpe (mftzznmcdr )
Positive
09 Nov 2020
Phase 2
192
jqlvegyrbu(yhfnmcnwme) = The vaccine was well tolerated with the most common adverse events being injection site reactions. snebzhrzbu (zyuexjhjfv )
Positive
01 Jun 2019
Placebo
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free